JP2020529208A5 - - Google Patents

Download PDF

Info

Publication number
JP2020529208A5
JP2020529208A5 JP2020505253A JP2020505253A JP2020529208A5 JP 2020529208 A5 JP2020529208 A5 JP 2020529208A5 JP 2020505253 A JP2020505253 A JP 2020505253A JP 2020505253 A JP2020505253 A JP 2020505253A JP 2020529208 A5 JP2020529208 A5 JP 2020529208A5
Authority
JP
Japan
Prior art keywords
mrna
utr
skin
fgf
systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020505253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020529208A (ja
Filing date
Publication date
Priority claimed from EP17183990.5A external-priority patent/EP3437650A1/en
Application filed filed Critical
Publication of JP2020529208A publication Critical patent/JP2020529208A/ja
Publication of JP2020529208A5 publication Critical patent/JP2020529208A5/ja
Priority to JP2023115343A priority Critical patent/JP2023145532A/ja
Pending legal-status Critical Current

Links

JP2020505253A 2017-07-31 2018-07-31 局所皮膚低栄養状態の治療 Pending JP2020529208A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023115343A JP2023145532A (ja) 2017-07-31 2023-07-13 局所皮膚低栄養状態の治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17183990.5A EP3437650A1 (en) 2017-07-31 2017-07-31 Treatment of local skin hypotrophy conditions
EP17183990.5 2017-07-31
PCT/EP2018/070712 WO2019025431A1 (en) 2017-07-31 2018-07-31 TREATMENT OF LOCAL SKIN HYPOTROPHIC CONDITIONS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023115343A Division JP2023145532A (ja) 2017-07-31 2023-07-13 局所皮膚低栄養状態の治療

Publications (2)

Publication Number Publication Date
JP2020529208A JP2020529208A (ja) 2020-10-08
JP2020529208A5 true JP2020529208A5 (cg-RX-API-DMAC7.html) 2021-09-09

Family

ID=59506101

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020505253A Pending JP2020529208A (ja) 2017-07-31 2018-07-31 局所皮膚低栄養状態の治療
JP2023115343A Withdrawn JP2023145532A (ja) 2017-07-31 2023-07-13 局所皮膚低栄養状態の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023115343A Withdrawn JP2023145532A (ja) 2017-07-31 2023-07-13 局所皮膚低栄養状態の治療

Country Status (8)

Country Link
US (1) US20200369738A1 (cg-RX-API-DMAC7.html)
EP (2) EP3437650A1 (cg-RX-API-DMAC7.html)
JP (2) JP2020529208A (cg-RX-API-DMAC7.html)
KR (1) KR20200035073A (cg-RX-API-DMAC7.html)
CN (1) CN111050785A (cg-RX-API-DMAC7.html)
AU (1) AU2018311128A1 (cg-RX-API-DMAC7.html)
CA (1) CA3070880A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019025431A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12115230B2 (en) * 2020-04-09 2024-10-15 Verve Therapeutics, Inc. Base editing of ANGPTL3 and methods of using same for treatment of disease
US20220015986A1 (en) * 2020-07-16 2022-01-20 Hillary Hayman Three-step process for mimicking plastic surgery results
CN114717230B (zh) * 2021-01-05 2024-09-03 麦塞拿治疗(香港)有限公司 成纤维细胞生长因子mRNA的无细胞和无载体体外RNA转录方法和核酸分子
WO2023012722A1 (en) * 2021-08-06 2023-02-09 Leadermed Champion Limited miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF
KR102432810B1 (ko) * 2021-10-29 2022-08-16 주식회사 엣지케어 약물전달 시스템 및 약물전달 시스템의 동작방법
US20240238473A1 (en) * 2023-01-09 2024-07-18 Beth Israel Deaconess Medical Center, Inc. Recombinant nucleic acid molecules and their use in wound healing
CN120137909A (zh) * 2025-03-12 2025-06-13 广州酷奇圈科研与推广应用有限公司 重组外泌体及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773002B2 (en) 1999-04-02 2004-05-13 Kci Licensing, Inc. Vacuum assisted closure system with provision for introduction of agent
US7202226B2 (en) * 2000-10-23 2007-04-10 Detroit R & D Augmentation of wound healing by elF-4E mRNA and EGF mRNA
US20070299032A1 (en) * 2003-11-11 2007-12-27 Shiseido Company, Ltd. Method and Composition for Thickening Hair
US7816140B2 (en) 2005-06-14 2010-10-19 The United States Of America As Represented By The Department Of Veterans Affairs Composition and methods for osteogenic gene therapy
BRPI0619967A2 (pt) * 2005-12-14 2011-10-25 Organogenesis Inc composições para o cuidado da pele
US20100143289A1 (en) 2006-12-19 2010-06-10 Michael Cohen Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
WO2009030464A2 (de) 2007-09-08 2009-03-12 Bayer Schering Pharma Aktiengesellschaft HERSTELLUNG UND VERWENDUNG VON VARIANTEN HUMANER KUNITZ-TYP PROTEASE-INHIBITOREN (hKTPI)
JP5553284B2 (ja) * 2008-03-28 2014-07-16 株式会社ラボ・ジュヴェルサ 皮膚の老化や瘢痕の治療剤
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
DK2670411T3 (da) 2011-02-02 2019-05-13 Excaliard Pharmaceuticals Inc Antisense-forbindelser rettet mod bindevævsvækstfaktor (CTGF) til anvendelse i en fremgangsmåde til behandling af keloider eller hypertrofiske ar
US8759287B2 (en) 2011-04-12 2014-06-24 M-3 Biologics, Llc Methods of decreasing incisional hernia formation and acute wound failure in obese patients by administering basic fibroblast growth factor
WO2013002331A1 (ja) * 2011-06-28 2013-01-03 株式会社バイオセレンタック 皮膚治療用微細針集積型製剤
US9439940B2 (en) 2011-07-19 2016-09-13 Neville Pharmaceutical, Inc. Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
WO2013120497A1 (en) * 2012-02-15 2013-08-22 Curevac Gmbh Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
US20150366997A1 (en) 2012-12-07 2015-12-24 Shire Human Genetics Therapies, Inc. COMPOSITIONS AND METHODS FOR mRNA DELIVERY
KR102311614B1 (ko) 2013-03-14 2021-10-08 샤이어 휴먼 지네틱 테라피즈 인크. Cftr mrna 조성물 및 관련 방법 및 사용
KR102415811B1 (ko) * 2014-01-31 2022-07-04 팩터 바이오사이언스 인크. 핵산 제조 및 송달을 위한 방법 및 산물
WO2016100820A2 (en) 2014-12-19 2016-06-23 Salk Institute For Biological Studies Fgf2 truncations and mutants and uses thereof
US11241505B2 (en) 2015-02-13 2022-02-08 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
WO2017191274A2 (en) * 2016-05-04 2017-11-09 Curevac Ag Rna encoding a therapeutic protein

Similar Documents

Publication Publication Date Title
JP2020515644A5 (cg-RX-API-DMAC7.html)
JP2023075165A (ja) 核酸生成及び送達のための方法及び製品
US20170087224A1 (en) Delivery methods and compositions
CN109381422B (zh) 一种经皮吸收组合物及其在制备经皮吸收制剂中的用途
JP2018506542A5 (cg-RX-API-DMAC7.html)
EP3275459A2 (en) Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition
Xing et al. Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia
KR102760486B1 (ko) 다중-인자 모발 성장 제제
Bhat et al. Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics?
JP2020529208A (ja) 局所皮膚低栄養状態の治療
KR20190123256A (ko) 액취증 치료 방법
Bhavsar et al. Strategies for transportation of peptides across the skin for treatment of multiple diseases
CN117050164A (zh) 透皮增强肽及其应用
CN112245571A (zh) 一种用于乌发的脂质体制剂及其制备方法
CN106084006B (zh) 一种透皮肽及其应用
Abdul Aziz et al. A review on the mechanisms, applications, and clinical trials of advanced technologies in the transdermal drug delivery system
CN121421927A (zh) 一种高活性外泌体生发促进剂的制备方法
WO2005039642B1 (en) Dna delivery with gemini cationic surfactants
RU2012146542A (ru) Способ ингибирования репликации вич в клетках млекопитающих и у людей
Zhang et al. mRNA-based therapeutics in skin regeneration and rejuvenation: From optimization strategies to translational advances
CN113316459A (zh) 包含皮肤穿透核酸复合物作为有效成分的用于预防或治疗特应性皮炎的组合物
EP1671655A1 (en) Gene therapy for skin diseases using needle free syringe
Chen et al. Research progress on the application of microneedle transdermal drug delivery system in dermatology
EP3490572A1 (en) Skin care formulation
Li et al. Elastin-like peptides for efficient and safe delivery of mRNA